Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   The p53 Inhibitor MDM2 Facilitates Sonic Hedgehog-Mediated Tumorigenesis and Influences Cerebellar Foliation
  2. Malek, R.; Matta, J.; Taylor, N.; Perry, M. E.; Mendrysa, S. M.
  3. Plos One. 2011, Mar; 6(3): 13.
  1. 2.   C/EBP ? targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression
  2. Pawar, S. A.; Sarkar, T. R.; Balamurugan, K.; Sharan, S.; Wang, J.; Zhang, Y. H.; Dowdy, S. F.; Huang, A. M.; Sterneck, E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, May 18; 107(20): 9210-9215.
  1. 4.   Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3 ' untranslated region
  2. Vondruskova, E.; Malik, R.; Sevcik, J.; Kleiblova, P.; Kleibl, Z.
  3. Neoplasma. 2008 55(2): 130-137.
  1. 5.   Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model
  2. Tang, B.; Yoo, N.; Vu, M.; Mamura, M.; Nam, J. S.; Ooshima, A.; Du, Z.; Desprez, P. Y.; Anver, M. R.; Michalowska, A. M.; Shih, J.; Parks, W. T.; Wakefield, L. M.
  3. Cancer Research. 2007, Sep; 67(18): 8643-8652.
  1. 6.   Loss of centrosome integrity induces p38-p53-p21dependent G1-S arrest
  2. Mikule, K.; Delaval, B.; Kaldis, P.; Jurcyzk, A.; Hergert, P.; Doxsey, S.
  3. Nature Cell Biology. 2007, Feb; 9(2): 160-U49.
  1. 7.   Stop and go - Anti-proliferative and mitogenic functions of the transcription factor C/EBP beta
  2. Sebastian, T.; Johnson, P. F.
  3. Cell Cycle. 2006, May; 5(9): 953-957.
  1. 8.   Tumor suppression and normal aging in mice with constitutively high p53 activity
  2. Mendrysa, S. M.; O'Leary, K. A.; McElwee, M. K.; Michalowski, J.; Eisenman, R. N.; Powell, D. A.; Perry, M. E.
  3. Genes & Development. 2006, JAN 1; 20(1): 16-21.
  1. 9.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 10.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 11.   Epigenetic and gene expression changes related to transgenerational carcinogenesis
  2. Cheng, R. Y. S.; Hockman, T.; Crawford, E.; Anderson, L. M.; Shiao, Y. H.
  3. Molecular Carcinogenesis. 2004 40(1): 1-11.
  1. 12.   Menin associates with a trithorax family histone methyltransferase complex and with the Hoxc8 locus
  2. Hughes, C. M.; Rozenblatt-Rosen, O.; Milne, T. A.; Copeland, T. D.; Levine, S. S.; Lee, J. C.; Hayes, D. N.; Shanmugam, K. S.; Bhattacharjee, A.; Biondi, C. A.; Kay, G. F.; Hayward, N. K.; Hess, J. L.; Meyerson, M.
  3. Molecular Cell. 2004 13(4): 587-597.
  1. 13.   Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins - A molecular link of two tumor suppressor pathways
  2. Birchenall-Roberts, M. C.; Fu, T.; Bang, O. S.; Dambach, M.; Resau, J. H.; Sadowski, C. L.; Bertolette, D. C.; Lee, H. J.; Kim, S. J.; Ruscetti, F. W.
  3. Journal of Biological Chemistry. 2004 279(24): 25605-25613.
  1. 14.   Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues
  2. O'Leary, K. A.; Mendrysa, S. M.; Vaccaro, A.; Perry, M. E.
  3. Molecular and Cellular Biology. 2004 24(1): 186-191.
  1. 15.   Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence
  2. Kammouni, W.; Ramakrishna, G.; Sithanandam, G.; Smith, G. T.; Fornwald, L. W.; Masuda, A.; Takahashi, T.; Anderson, L. M.
  3. Cell Growth and Differentiation. 2002 13(9): 441-448.
  1. 16.   INK4a-deficient human diploid fibroblasts are resistant to RAS- induced senescence
  2. Brookes, S.; Rowe, J.; Ruas, M.; Llanos, S.; Clark, P. A.; Lomax, M.; James, M. C.; Vatcheva, R.; Bates, S.; Vousden, K. H.; Parry, D.; Gruis, N.; Smit, N.; Bergman, W.; Peters, G.
  3. Embo Journal. 2002 21(12): 2936-2945.
  1. 17.   Activation of the p53 tumor suppressor protein
  2. Vousden, K. H.
  3. Biochimica Et Biophysica Acta-reviews on Cancer. 2002 1602(1): 47-59.
  1. 18.   Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids
  2. Athanasiou, M.; LeGallic, L.; Watson, D. K.; Blair, D. G.; Mavrothalassitis, G.
  3. Cancer Gene Therapy. 2000, Aug; 7(8): 1188-1195.
  1. 19.   A ribonucleotide reductase gene is a transcriptional target of p53 and p73
  2. Nakano, K.; Balint, E.; Ashcroft, M.; Vousden, K. H.
  3. Oncogene. 2000 19(37): 4283-4289.
  1. 20.   Role of the alternative INK4A proteins in human keratinocyte senescence: Evidence for the specific inactivation of p16(INK4A) upon immortalization
  2. Munro, J.; Stott, F. J.; Vousden, K. H.; Peters, G.; Parkinson, E. K.
  3. Cancer Research. 1999 59(11): 2516-2521.
  1. 21.   Abrogation of Rb Tumor Suppression Initiates GBM in Differentiated Astrocytes by Driving a Progenitor Cell Program
  2. Adhikari, Amit S; Sullivan,Teresa; Bargaje, Rhishikesh; Lu, Lucy; O'Sullivan,Theresa; Song,Yurong; Van Dyke, Terry
  3. Frontiers in Oncology. 2022 12: 904479.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel